Bottom line
How much do PHSYX and SCHLX overlap?
70% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 69.0% of PHSYX's assets and 61.8% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHSYX and SCHLX have in common
| Holding | % of PHSYX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.85% | 13.15% |
| Johnson & Johnson | 8.46% | 6.19% | 6.19% |
| UnitedHealth Group, Inc. | 6.93% | 5.73% | 5.73% |
| AbbVie, Inc. | 6.05% | 4.90% | 4.90% |
| Merck & Co., Inc. | 4.88% | 4.85% | 4.85% |
| AstraZeneca plc | 4.67% | 3.80% | 3.80% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.46% | 3.46% |
| Intuitive Surgical, Inc. | 4.04% | 2.69% | 2.69% |
| Roche Holding AG | 2.79% | 1.24% | 1.24% |
| Gilead Sciences, Inc. | 2.63% | 2.78% | 2.63% |
| McKesson Corp. | 2.14% | 2.05% | 2.05% |
| Cardinal Health, Inc. | 2.12% | 1.34% | 1.34% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 2.45% | 1.97% |
| Boston Scientific Corp. | 1.80% | 2.10% | 1.80% |
| Bristol-Myers Squibb Co. | 1.75% | 1.50% | 1.50% |
| Amgen, Inc. | 1.11% | 2.88% | 1.11% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHSYX
- Novartis AG — 5.13%
- Sanofi SA — 3.23%
- Edwards Lifesciences Corp. — 2.80%
- CVS Health Corp. — 2.74%
- Novo Nordisk A/S — 1.90%
- Dexcom, Inc. — 1.64%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
- HCA Healthcare, Inc. — 1.18%
Only in SCHLX
- Novartis AG — 2.90%
- Stryker Corp — 2.61%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Regeneron Pharmaceuticals Inc — 1.43%
- Cencora Inc — 1.26%
- Pfizer Inc — 1.17%
Asset mix
| Asset type | PHSYX | SCHLX |
|---|---|---|
| Stocks | 98.2% | 99.6% |
| Other | 1.4% | — |
| Cash & short-term funds | 0.6% | 0.5% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | PHSYX | SCHLX |
|---|---|---|
| US | 76.2% | 85.7% |
| CH | 7.9% | 5.2% |
| GB | 6.4% | 3.8% |
| FR | 3.2% | 1.0% |
| DK | 2.4% | 1.7% |
| JP | 2.4% | — |
| IE | — | 1.5% |
| NL | 1.2% | 1.0% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PHSYX and SCHLX overlap?
What stocks do PHSYX and SCHLX have in common?
Should I own both PHSYX and SCHLX?
Which holds more stocks, PHSYX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.